| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $12.8M | $13.9M | $14.0M |
| YoY Revenue Growth % | -7.6% | -1.4% | — |
| Gross Profit | -$204.0K | $2.3M | — |
| Gross Margin % | -1.6% | 16.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$15.8M | -$9.3M | -$9.9M |
| Operating Margin % | -80.0% | -66.9% | -70.3% |
| Net Income (GAAP) | -$17.3M | -$11.1M | -$10.2M |
| EBITDA (Normalized) | -$15.3M | -$9.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$11.8M | -$8.5M | -$8.5M |
| Capital Expenditures (CapEx) | $638.0K | $303.0K | — |
| Free Cash Flow (FCF) | -$12.4M | -$8.8M | -$8.5M |
| FCF Margin % | -80.0% | -63.6% | -60.7% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $215.0K | $544.0K | — |
| Total Stockholders' Equity | $12.5M | $4.1M | — |